News
King Pharmaceuticals Canada launches new EpiPenŽ featuring user-friendly design
It’s Life and Death: Canadian Actress Speaks Out About Living with Severe Allergies
New Study Shows Most Canadians Not Prepared for Potentially Fatal Allergic Reactions
Montréal Broadcaster Normand Brathwaite Advises Quebeckers to Prepare for Allergy Season
King Pharmaceuticals Canada Launches EpiPen® Expiration Reminder
King Pharmaceuticals Acquires Exclusive Rights to EpiPen® in Canada
We're Making Connections
King Pharmaceuticals, Inc. established King Pharmaceuticals Canada in 2006 with the goal of applying our resources and capabilities to help meet Canada's healthcare needs. King is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in cardiovascular/metabolics, neuroscience, and hospital/acute care. King has unique strengths in commercialization, advanced clinical development, manufacturing, and regulatory affairs, which make the company a proven partner of choice for late stage compounds and novel branded prescription pharmaceutical products and technologies.
In Canada, King's leading brands include EpiPen®, Cytomel® and Bicillin® L-A .
Our unique strengths, resources and integrated capabilities make King a proven partner of choice.
Fast Facts - King at-a-glance.